APAC CT Market

APAC CT Market Size (2024 to 2029)

The CT market size in the Asia Pacific was worth USD 1.10 billion in 2024 and is estimated to reach USD 1.36 billion by the end of 2029, with a CAGR of 4.93%.

CT scan, Computed Tomography, is a body imaging technique that uses tomography and digital geometry to generate a 3D image of a body's internal organs. It uses two-dimensional x-rays taken around a single axis of rotation and then developed to form the 3D image.

The APAC CT market is projected to be fuelled by increasing usage of CT scans to access the efficacy of post-interventional medical treatments and growing demand for bedside imaging and medical implants.  In addition, increasing demand for home healthcare and the growing use of CT scans to assess the efficacy of post-interventional medical treatments, medical implants, and anatomical confirmations propel the market forward in this region. Furthermore, chronic diseases such as cancer and orthopedic, cardiovascular, and dental disorders are becoming more common in Asia. It is expected to favor regional market growth during the forecast period. 

Furthermore, the number of medical implant operations is predicted to rise due to changing lifestyles and an aging population. On the other hand, the market is also expanding due to the government's increased demands for high-quality healthcare infrastructure and the availability of healthcare services to people across the region.  Moreover, imaging technology improvements promise to boost well-being by providing faster and more accurate diagnoses of medical problems. The growing older population and rising frequency of chronic diseases, and a shift in medical care toward image-guided interventions and technical advancements are further driving the APAC CT market. 

However, rising fiscal deficits may hamper the growth of the Asia Pacific CT market in industrialized countries. Furthermore, the CT imaging radiation dose remains a source of concern. Many patients and medical organizations have raised this problem and spoken out against the potential side effects of CT scanning. As a result, the APAC CT market focuses on minimizing exposure while maintaining image quality.

This research report on the Asia Pacific CT market has been segmented & sub-segmented into the following categories:

By Low-slice Type: 

• Single Slice
• Dual Slice

By Slice Type: 

• 6 Slice
• 10 Slice
• 16 Slice
• 32 Slice

By High-slice Type: 

• 40 Slice
• 64 Slice
• Open Versions
• Cardiac CT

By End-Users: 

• Hospitals and Clinics
• Imaging Centers
• Others

By Country: 

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the Asia Pacific CT market is one of the fastest-growing regions globally. Asia Pacific is likely to lead the market and rise at a faster CAGR during the forecast period. This, combined with an extensive and outdated installed base CT scan that must be replaced, presents a significant opportunity for new systems in this region. The regional market growth is expected to be driven by the rising incidence of chronic diseases, the burgeoning healthcare sector, and a substantial unmet need for improved diagnostic systems in diagnostic centers. The emerging countries in the region, such as China, Japan, India, Australia, and the rest of the Asia Pacific, are the countries that are expanding the Asia Pacific CT market.

The Japanese CT market is projected to showcase a healthy CAGR during the forecast period. Japan's population is aging at a rapid rate in the region. According to the World Ageing 2019 study, Japan's population over 65 was 35.524 million (28%) in 2019 and is expected to reach 37.278 million (30.9%) in 2030. The number of seniors is likely to rise in the coming years, making them more vulnerable to chronic diseases like cancer, chronic disease, respiratory disease, diabetes, and other illnesses. CT scans are increasingly being utilized to diagnose these disorders, driving demand and indicating a significant increase soon.

The China CT market is likely to witness a predominant share in the APAC market during the forecast period. According to Globocan 2018, there were around 4,285,033 new cancer cases in China in 2018, with approximately 2,865,174 deaths. The leading cancers in China in 2018 were lung, colorectum, stomach, liver, and breast cancer. The rising cancer burden is attributable to various variables, such as population increase and aging, and the changing prevalence of different cancers is linked to social and economic development. In addition, cancer is associated with lifestyle. Because CT scans are less expensive than other imaging modalities, the category is likely to grow at a respectable rate during the projection period.

KEY MARKET PLAYERS

A few of the noteworthy companies operating in the APAC CT market profiled in this report are GE Healthcare, Hitachi Medical Corporation, Hitachi Medical Systems America, Inc., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Philips Healthcare, Shenzhen Anke High-Tech Co., Siemens Healthcare, and Toshiba Medical Systems Corporation.